MAM
McCann appoints Joe DiMeglio to handle General Motors account
MUMBAI: McCann Worldgroup has appointed Joe DiMeglio as EVP, worldwide account director for its global General Motors business including Chevrolet, Vauxhall, Opel and Holden.
DiMeglio, joins from Organic, where he was EVP, chief client officer, and also has extensive automotive marketing experience from his previous positions at J. Walter Thompson Co. in Detroit.
In taking on operational and management oversight of McCann Worldgroup’s global General Motors business, DiMeglio will leverage Worldgroup’s full worldwide and multidiscipline capabilities to deliver multiplatform strategic and creative solutions. This will encompass working collaboratively across all Worldgroup business units currently serving GM brands, including Commonwealth//McCann (Worldgroup’s globally dedicated Chevrolet agency), MRM//McCann, Weber Shandwick, Momentum and Craft.
Commonwealth//McCann chairman and CEO Bill Kolb said, “We are pleased to welcome Joe. He has been associated with outstanding work. His deep understanding of the automotive category combined with his digital and multiplatform communications expertise will help strengthen our ability to grow and develop GM’s Chevrolet brand across the globe.”
As EVP and chief client officer for Organic, DiMeglio led the client service discipline, overseeing the management of Organic’s clients. Previously, he was general manager of Organic’s Detroit office. During his decade-long tenure with Organic he managed the overall relationship and project execution for many of the agency’s largest clients, including Chrysler, Hilton, Toyota and Volkswagen.
Prior to joining Organic, DiMeglio was SVP and group director at J. Walter Thompson, where he successfully managed cross-functional teams for the Ford Truck and SUV account.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
